Trends in Seroprevalence of Herpes Simplex Virus Type 2 Among Non-Hispanic Blacks and Non-Hispanic Whites Aged 14 to 49 Years—United States, 1988 to 2010

Fanfair, Robyn Neblett; Zaidi, Akbar A.; Taylor, La Shan D.; Xu, Fujie; Gottlieb, Sami L.; Markowitz, Lauri E.

doi:10.1097/olq.0000000000000043

Cited by 58 publications

(57 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Finally, of the major causes of US life-expectancy disadvantage—caloric consumption patterns, gun violence, drug overdoses, unprotected sexual intercourse, environments that hinder physical activity, barriers to health care access, child poverty, and high (and rising) income inequality— few indicate significant signs of improvement since the early 2000s (see Flegal et al 23 and Ogden et al 24 on stably high obesity levels but Welsh et al 25 and Kit et al 26 on reductions in the consumption of added sugars; Marczak et al 27 on marginal declines in firearm death but Rudd et al 28 on the tripling in drug overdose death; Liu et al 29 on stability in adolescent sexual behavior, Fanfair et al 30 on some reductions in sexually transimitted infection seroprevalance; Institute for Research on Poverty 31 on increases in child poverty; and Saez and Zucman 32 on increases in wealth inequality).…”

Section: Discussionmentioning

confidence: 99%

Meeting the Institute of Medicine's 2030 US Life Expectancy Target

2018

View full text Add to dashboard Cite

Objectives To quantify the improvement in US life expectancy required to reach parity with high-resource nations by 2030, to document historical precedent of this rate, and to discuss the plausibility of achieving this rate in the United States. Methods We performed a demographic analysis of secondary data in 5-year periods from 1985 to 2015. Results To achieve the United Nations projected mortality estimates for Western Europe in 2030, the US life expectancy must grow at 0.32% a year between 2016 and 2030. This rate has precedent, even in low-mortality populations. Over 204 country-periods examined, nearly half exhibited life-expectancy growth greater than 0.32%. Of the 51 US states observed, 8.2% of state-periods demonstrated life-expectancy growth that exceeded the 0.32% target. Conclusions Achieving necessary growth in life expectancy over the next 15 years despite historical precedent will be challenging. Much all-cause mortality is structured decades earlier and, at present, older-age mortality reductions in the United States are decelerating. Addressing mortality decline at all ages will require enhanced political will and a strong commitment to equity improvement in the US population.

show abstract

Section: Discussionmentioning

confidence: 99%

Meeting the Institute of Medicine's 2030 US Life Expectancy Target

2018

View full text Add to dashboard Cite

show abstract

“…HSV-2 seroprevalence was also found to have declined by 4.8% per year among pregnant women in Seattle for the period 1989 to 2010 (8). The declining seroprevalence has been seen mostly in white persons, with stable rates in black populations, resulting in worsening racial disparities such that for every one white man, four black men are infected, with similar ratios for women (7). Disparities have also been noted in black young men who have sex with men (MSM) (9) and pregnant women (8).…”

Section: Hsv-2 Epidemiology By Geographic Regionmentioning

confidence: 92%

“…In the United States, seroprevalence has declined in 14-to 49-year-olds in recent years, from a high of 21.2% in 1988 to 1994 to 15.5% in the most recent 2007 to 2010 National Health and Nutrition Examination Survey (NHANES), a population-based estimate of U.S. adults (7). HSV-2 seroprevalence was also found to have declined by 4.8% per year among pregnant women in Seattle for the period 1989 to 2010 (8).…”

Section: Hsv-2 Epidemiology By Geographic Regionmentioning

confidence: 99%

Current Concepts for Genital Herpes Simplex Virus Infection: Diagnostics and Pathogenesis of Genital Tract Shedding

2016

View full text Add to dashboard Cite

SUMMARY Herpes simplex virus 2 (HSV-2) is a DNA virus that is efficiently transmitted through intimate genital tract contact and causes persistent infection that cannot be eliminated. HSV-2 may cause frequent, symptomatic self-limited genital ulcers, but in most persons infection is subclinical. However, recent studies have demonstrated that the virus is frequently shed from genital surfaces even in the absence of signs or symptoms of clinical disease and that the virus can be transmitted during these periods of shedding. Furthermore, HSV-2 shedding is detected throughout the genital tract and may be associated with genital tract inflammation, which likely contributes to increased risk of HIV acquisition. This review focuses on HSV diagnostics, as well as what we have learned about the importance of frequent genital HSV shedding for (i) HSV transmission and (ii) genital tract inflammation, as well as (iii) the impact of HSV-2 infection on HIV acquisition and transmission. We conclude with discussion of future areas of research to push the field forward.

show abstract

“…También es importante anotar que la relación en la seroprevalencia mayor mujeres/hombres no se limita solamente al VPH. La seroprevalencia del virus herpes simple tipo 2 (HSV-2) es significativamente menor en hombres que en mujeres, pues es casi dos veces mayor la seroprevalencia de HSV-2 en mujeres (20,3 %) en contraste con los hombres (10,6 %) (18).…”

Section: Seroprevalencia Ante La Infección Del Virus Del Papiloma Humanounclassified

Naprotecnología: ciencia y persona en la infección por el virus del papiloma humano (VPH) en mujeres y preadolescencentes

et al. 2017

View full text Add to dashboard Cite

En la actualidad hay suficiente evidencia científica que relaciona directamente adquisición, exposición y prevalencia del virus del papiloma humano (VPH) con el cáncer del cuello de uterino. Por ello, el artículo aborda el VPH en la mujer teniendo en cuenta la naprotecnología, que permite conjugar evidencia científica y planteamientos éticos. Se busca que se tengan en cuenta tanto el aspecto biológico de la sexualidad como la capacidad de hacerse persona en su núcleo sexual. De ahí que se analicen programas dirigidos a la educación sexual, basados tanto en la prevención sanitaria como en la antropología de la sexualidad, y apoyados por las instituciones familiares, que han demostrado una mejor acogida ante los riesgos de las enfermedades de transmisión sexual, y entre ellas la infección por el VPH.

show abstract

Trends in Seroprevalence of Herpes Simplex Virus Type 2 Among Non-Hispanic Blacks and Non-Hispanic Whites Aged 14 to 49 Years—United States, 1988 to 2010

Abstract: Although HSV-2 seroprevalence decreased overall, the decrease was most marked among non-Hispanic whites, and racial disparities significantly increased over time. These persistent disparities demonstrate the need for innovative prevention strategies among this at-risk population.

Cited by 58 publications

References 22 publications

Meeting the Institute of Medicine's 2030 US Life Expectancy Target

Meeting the Institute of Medicine's 2030 US Life Expectancy Target

Current Concepts for Genital Herpes Simplex Virus Infection: Diagnostics and Pathogenesis of Genital Tract Shedding

Naprotecnología: ciencia y persona en la infección por el virus del papiloma humano (VPH) en mujeres y preadolescencentes

Contact Info

Product

Resources

About